Serum lidocaine (lignocaine) concentrations during prolonged perioperative infusion in patients undergoing breast cancer surgery: A secondary analysis of a randomised controlled trial.
Saved in:
| Title: | Serum lidocaine (lignocaine) concentrations during prolonged perioperative infusion in patients undergoing breast cancer surgery: A secondary analysis of a randomised controlled trial. |
|---|---|
| Authors: | Toner AJ; Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia., Bailey MA; Department of Anaesthesia and Intensive Care Medicine, Taranaki Base Hospital, New Plymouth, New Zealand., Schug SA; Medical School, University of Western Australia, Perth, Australia., Phillips M; Harry Perkins Institute of Medical Research, Nedlands, Australia.; Centre for Medical Research, University of Western Australia, Perth, Australia., Ungerer JP; Pathology Queensland, Royal Brisbane & Women's Hospital, Brisbane, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, Australia., Somogyi AA; Discipline of Pharmacology, School of Biomedicine, University of Adelaide, Adelaide, Australia., Corcoran TB; Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. |
| Source: | Anaesthesia and intensive care [Anaesth Intensive Care] 2023 Nov; Vol. 51 (6), pp. 422-431. Date of Electronic Publication: 2023 Oct 06. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 0342017 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0310-057X (Print) Linking ISSN: 0310057X NLM ISO Abbreviation: Anaesth Intensive Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
